Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin A Nacev

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Nucleic Acids Research|March 13, 2024
ATRX guards against aberrant differentiation in mesenchymal progenitor cellsYan Fang, Douglas Barrows, Yakshi Dabas, et al.
Journal of Surgical Case Reports|October 20, 2014
Traumatic ventricular septal defect resulting in severe pulmonary hypertensionJoseph G Crompton, Benjamin A Nacev, Trevor Upham, et al.
Molecular Cancer Therapeutics|March 29, 2011
High-throughput screen identifies novel inhibitors of cancer biomarker α-methylacyl coenzyme A racemase (AMACR/P504S)Brice A P Wilson, Haofan Wang, Benjamin A Nacev, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 10, 2022
The genetic landscape of SMARCB1 alterations in SMARCB1-deficient spectrum of mesenchymal neoplasmsJosephine K Dermawan, Samuel Singer, William D Tap, et al.
Nature Reviews. Cancer|August 13, 2020
The epigenomics of sarcomaBenjamin A Nacev, Kevin B Jones, Andrew M Intlekofer, et al.
Nature Chemical Biology|March 2, 2021
Oncohistone mutations enhance chromatin remodeling and alter cell fatesJohn D Bagert, Michelle M Mitchener, Agata L Patriotis, et al.
Nature|March 22, 2019
The expanding landscape of 'oncohistone' mutations in human cancersBenjamin A Nacev, Lijuan Feng, John D Bagert, et al.
ACS Chemical Biology|January 21, 2017
Simultaneous Targeting of NPC1 and VDAC1 by Itraconazole Leads to Synergistic Inhibition of mTOR Signaling and AngiogenesisSarah A Head, Wei Q Shi, Eun Ju Yang, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 13, 2011
A calcineurin-independent mechanism of angiogenesis inhibition by a nonimmunosuppressive cyclosporin A analogBenjamin A Nacev, Woon-Kai Low, Zhennian Huang, et al.
Journal of the National Cancer Institute|November 20, 2010
Effect of nitroxoline on angiogenesis and growth of human bladder cancerJoong Sup Shim, Yoshiyuki Matsui, Shridhar Bhat, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Nucleic Acids Research|March 13, 2024
ATRX guards against aberrant differentiation in mesenchymal progenitor cellsYan Fang, Douglas Barrows, Yakshi Dabas, et al.
Journal of Surgical Case Reports|October 20, 2014
Traumatic ventricular septal defect resulting in severe pulmonary hypertensionJoseph G Crompton, Benjamin A Nacev, Trevor Upham, et al.
Molecular Cancer Therapeutics|March 29, 2011
High-throughput screen identifies novel inhibitors of cancer biomarker α-methylacyl coenzyme A racemase (AMACR/P504S)Brice A P Wilson, Haofan Wang, Benjamin A Nacev, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 10, 2022
The genetic landscape of SMARCB1 alterations in SMARCB1-deficient spectrum of mesenchymal neoplasmsJosephine K Dermawan, Samuel Singer, William D Tap, et al.
Nature Reviews. Cancer|August 13, 2020
The epigenomics of sarcomaBenjamin A Nacev, Kevin B Jones, Andrew M Intlekofer, et al.
Nature Chemical Biology|March 2, 2021
Oncohistone mutations enhance chromatin remodeling and alter cell fatesJohn D Bagert, Michelle M Mitchener, Agata L Patriotis, et al.
Nature|March 22, 2019
The expanding landscape of 'oncohistone' mutations in human cancersBenjamin A Nacev, Lijuan Feng, John D Bagert, et al.
ACS Chemical Biology|January 21, 2017
Simultaneous Targeting of NPC1 and VDAC1 by Itraconazole Leads to Synergistic Inhibition of mTOR Signaling and AngiogenesisSarah A Head, Wei Q Shi, Eun Ju Yang, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 13, 2011
A calcineurin-independent mechanism of angiogenesis inhibition by a nonimmunosuppressive cyclosporin A analogBenjamin A Nacev, Woon-Kai Low, Zhennian Huang, et al.
Journal of the National Cancer Institute|November 20, 2010
Effect of nitroxoline on angiogenesis and growth of human bladder cancerJoong Sup Shim, Yoshiyuki Matsui, Shridhar Bhat, et al.
Pageof 4